Advanced search
Publication Cover
Journal of Pain Research Volume 13, 2020 - Issue
Submit an article Journal homepage
70
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic

John Ngo1 Department of Anesthesiology and Pain Management, University of Texas Medical Branch, Galveston, TX, USA
,
David Parker2 Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA
,
Mathew Meroney3 Department of Anesthesiology and Pain Management, University of Florida, Gainesville, FL, USA
,
Jasmine Mitchell2 Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA
,
Oscar Veloz4 Department of Anesthesia, Mcgaw Northwestern University Medical Center, Chicago, IL, USA
,
Oliver Lee5 Department of Anesthesia, University of Washington, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0002-5494-8927
ORCID Icon,
Katherine A Cunningham2 Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USAORCID Iconhttps://orcid.org/0000-0002-4257-1739
ORCID Icon &
Denise Wilkes1 Department of Anesthesiology and Pain Management, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
 show all
Pages 2163-2168 | Published online: 25 Aug 2020

References

  • Abuse NIoD. Overdose Death Rates, (ed 1/19). Available from: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed July 20, 2020.
  • Fuentes AV, Pineda MD, Venkata KCN. Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy (Basel). 2018;6.
  • Jones CM, Lurie PG, Throckmorton DC. Effect of US drug enforcement administration’s rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176(3):399–402. doi:10.1001/jamainternmed.2015.7799
  • Guy GP Jr., Shults RA. Opioid prescribing in the United States. Am J Nurs. 2018;118(2):19–20. doi:10.1097/01.NAJ.0000530238.99144.e8
  • Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007–2012. Am J Prev Med. 2015;49:409–413. doi:10.1016/j.amepre.2015.02.020
  • Breuer B, Cruciani R, Portenoy RK. Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. South Med J. 2010;103(8):738–747. doi:10.1097/SMJ.0b013e3181e74ede
  • Fleming ML, Driver L, Sansgiry SS, et al. Physicians’ intention to prescribe hydrocodone combination products after rescheduling: a theory of reasoned action approach. Res Social Adm Pharm. 2017;13:503–512. doi:10.1016/j.sapharm.2016.07.001
  • Schultz S, Chamberlain C, Vulcan M, Rana H, Patel B, Alexander JC. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. J Opioid Manag. 2016;12(2):119–122. doi:10.5055/jom.2016.0323
  • Oehler EC, Day RL, Robinson DB, Brown LH. Has the rescheduling of hydrocodone changed ED prescribing practices? Am J Emerg Med. 2016;34(12):2388–2391. doi:10.1016/j.ajem.2016.09.002
  • Bigal LM, Bibeau K, Dunbar S. Tramadol prescription over a 4-year period in the USA. Curr Pain Headache Rep. 2019;23(10):76. doi:10.1007/s11916-019-0777-x
  • Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. doi:10.2165/00003088-200443130-00004
  • Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 1996;15(1):8–29. doi:10.2165/00002018-199615010-00002
  • Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend. 2013;129(1–2):116–124. doi:10.1016/j.drugalcdep.2012.09.018
  • Handley SA, Flanagan RJ. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011. Clin Toxicol (Phila). 2014;52(1):1–12. doi:10.3109/15563650.2013.872791
  • Control BIN. Report for the International Narcotics Control Board for 2018. New York; 2018.
  • Report USNaW. How Tramadol, Touted as Safer Opioid, Became 3rd World Peril. Press A, (ed);2019.
  • Nafziger AN, Barkin RL. Opioid therapy in acute and chronic pain. J Clin Pharmacol. 2018;58:1111–1122. doi:10.1002/jcph.1276
  • Hassamal S, Miotto K, Dale W, Tramadol: DI. Understanding the risk of serotonin syndrome and seizures. Am J Med. 2018;131(1382):e1381–1382 e1386. doi:10.1016/j.amjmed.2018.04.025
  • Beyaz SG, Sonbahar T, Bayar F, Erdem AF. Seizures associated with low-dose tramadol for chronic pain treatment. Anesth Essays Res. 2016;10(2):376–378. doi:10.4103/0259-1162.177181

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.